Tao He

1Department Of Gastroenterology & Hepatology, 28 Fuxing Road
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

HPD is a copper-binding protein that interacts with DLAT to promote colorectal cancer cuproptosis under copper stress.

HPD is a copper-binding protein that interacts with DLAT to promote colorectal cancer cuproptosis under copper stress.

Journal: Cell reports

Published: January 19, 2026

CCS facilitates the progression of ovarian cancer by suppressing ferroptotic cell death via the modulation of p53-mediated expression of SLC7A11 and GPX4.

CCS facilitates the progression of ovarian cancer by suppressing ferroptotic cell death via the modulation of p53-mediated expression of SLC7A11 and GPX4.

Journal: Acta pharmacologica Sinica

Published: October 08, 2025

Atox1 promotes CRC progression by protecting DNA damage through interacts with a novel copper-binding protein PARP1.

Atox1 promotes CRC progression by protecting DNA damage through interacts with a novel copper-binding protein PARP1.

Journal: Cell communication and signaling : CCS

Published: October 05, 2025

USP30 senses serine/glycine levels to regulate serine biosynthesis and colorectal tumorigenesis by deubiquitinating FTO.

USP30 senses serine/glycine levels to regulate serine biosynthesis and colorectal tumorigenesis by deubiquitinating FTO.

Journal: Cell death and differentiation

Published: June 09, 2025

HPD is an RNA-Binding Protein Sustaining Ovarian Cancer Cell Glycolysis, Tumor Growth, and Drug Resistance.

HPD is an RNA-Binding Protein Sustaining Ovarian Cancer Cell Glycolysis, Tumor Growth, and Drug Resistance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 03, 2025

The non-metabolic function of 6PGD coordinates CCNA2 and HMGA2 expression to drive colorectal cancer progression and drug response.

The non-metabolic function of 6PGD coordinates CCNA2 and HMGA2 expression to drive colorectal cancer progression and drug response.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 15, 2025

Identification of TAT as a Biomarker Involved in Cell Cycle and DNA Repair in Breast Cancer.

Identification of TAT as a Biomarker Involved in Cell Cycle and DNA Repair in Breast Cancer.

Journal: Biomolecules

Published: July 10, 2024

Management of patient with Fusobacterim nucletum related pleural empyema: intrapleural antibiotic therapy can be considered for salvage therapy.

Management of patient with Fusobacterim nucletum related pleural empyema: intrapleural antibiotic therapy can be considered for salvage therapy.

Journal: BMC infectious diseases

Published: March 28, 2024

Genomic characterization and risk stratification of esophageal squamous dysplasia.

Genomic characterization and risk stratification of esophageal squamous dysplasia.

Journal: Medical review (2021)

Published: January 29, 2024

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling.

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling.

Journal: Cancer biology & therapy

Published: January 16, 2024

Epigenetic silencing schlafen-11 sensitizes esophageal cancer to ATM inhibitor.

Epigenetic silencing schlafen-11 sensitizes esophageal cancer to ATM inhibitor.

Journal: World journal of gastrointestinal oncology

Published: November 30, 2023

The dysfunctional Wnt pathway down-regulates MLH1/SET expression and promotes microsatellite instability and immunotherapy response in colorectal cancer.

The dysfunctional Wnt pathway down-regulates MLH1/SET expression and promotes microsatellite instability and immunotherapy response in colorectal cancer.

Journal: Genes & diseases

Published: October 08, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026